These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6393495)

  • 21. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 22. Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.
    Miyazaki S; Miura K; Kasai Y; Abe K; Yoshinaga K
    Br Med J (Clin Res Ed); 1982 Jan; 284(6312):310-11. PubMed ID: 6174171
    [No Abstract]   [Full Text] [Related]  

  • 23. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
    Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local treatment with isosorbide dinitrate ointment in Raynaud's phenomenon].
    Diehm C; Müller-Bühl U; Mechterscheimer U; Mörl H
    Vasa; 1984; 13(1):72-4. PubMed ID: 6367258
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract]   [Full Text] [Related]  

  • 27. [Captopril and diuretics].
    Cremer W
    MMW Munch Med Wochenschr; 1982 Nov; 124(47):1067-9. PubMed ID: 6817123
    [No Abstract]   [Full Text] [Related]  

  • 28. Nifedipine for Raynaud's phenomenon.
    Lancet; 1983 Jan; 1(8316):130. PubMed ID: 6129447
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of a pure anti-platelet drug to decrease the number of attacks more than placebo in patients with Raynaud's phenomenon.
    Destors JM; Gauthier E; Lelong S; Boissel JP
    Angiology; 1986 Aug; 37(8):565-9. PubMed ID: 2943195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiological classification of Raynaud's syndrome].
    Kristensen JK; Nielsen HV
    Ugeskr Laeger; 1984 May; 146(22):1619-21. PubMed ID: 6393476
    [No Abstract]   [Full Text] [Related]  

  • 32. [Captopril-a new principle in the treatment of hypertension].
    Forslund T; Fyhrquist F
    Tidsskr Nor Laegeforen; 1981 Aug; 101(23):1290-2. PubMed ID: 7022744
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of Raynaud's phenomenon].
    Lazareth I
    Ann Dermatol Venereol; 1987; 114(8):1035-8. PubMed ID: 2892456
    [No Abstract]   [Full Text] [Related]  

  • 34. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
    Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
    Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study].
    Saragoça M; Ribeiro AB; Ramos OL
    Arq Bras Cardiol; 1982 May; 38(5):415-9. PubMed ID: 6762867
    [No Abstract]   [Full Text] [Related]  

  • 36. Diltiazem and Raynaud's syndrome.
    Matoba T; Ogata M; Kuwahara H
    Ann Intern Med; 1982 Sep; 97(3):455. PubMed ID: 7051914
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficacy and safety of low doses of captopril, alone or combined with diuretics in the treatment of mild or moderate hypertension].
    Castilho F; Faria Neto A; Santos Neto FB; Assad JE; Levigard RM
    Arq Bras Cardiol; 1984 Oct; 43(4):283-6. PubMed ID: 6399202
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of sublingual captopril and nifedipine in hypertensive crises.
    Pujadas R; Jané J; Fornós C; Gago MJ; de la Concepción N
    Arch Intern Med; 1987 Jan; 147(1):175-6. PubMed ID: 3541822
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic efficacy of alpha-adrenoceptor blockade in primary and secondary Raynaud's syndrome.
    Cleophas TJ; van Lier HJ; Faaber P; Fennis JF; van't Laar A
    Angiology; 1984 Nov; 35(11):719-23. PubMed ID: 6149709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1996 Nov; 23(11):1917-20. PubMed ID: 8923366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.